ENGOT-cx1/BGOG-cx1

Trial Description: 
Randomized double-blind Phase II study comparing carboplatin + paclitaxel with or without concomitant and maintenance Nintedanib in advanced or recurrent cervical carcinoma
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Cervical
Trial Status: 
Closed to Recruitment
Contact person: